| Symbol | EYPT |
|---|---|
| Name | EYEPOINT, INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Laboratory Analytical Instruments |
| Address | 480 PLEASANT STREET, WATERTOWN, MA 02472 |
| Telephone | 617-926-5000 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001314102 |
| Description | None |
New Form SCHEDULE 13G - EyePoint, Inc. <b>Filed:</b> 2026-07-31 <b>AccNo:</b> 0002100119-26-001390 <b>Size:</b> 7 KB
Read more(10% Negative) EYEPOINT, INC. (EYPT) Announces Delay in option Trials for five months Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment
Read moreEyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU™ for Treatment of Diabetic Macular Edema (DME)
Read moreNew Form 144/A - EyePoint, Inc. <b>Filed:</b> 2026-07-22 <b>AccNo:</b> 0001959173-26-005330 <b>Size:</b> 5 KB
Read moreNew Form 144/A - EyePoint, Inc. <b>Filed:</b> 2026-07-22 <b>AccNo:</b> 0001959173-26-005318 <b>Size:</b> 4 KB
Read more📋 Lurker Nancy (Officer) plans to sell 421K shares of EyePoint, Inc. (at $13.05 each, total $5.5M) Filed: Jul 21, 2026 | ID: 005309
Read moreRibeiro Ramiro 🟡 adjusted position in 4.9K shares (2 derivative) of EyePoint, Inc. (EYPT) at $15.02 Transaction Date: Jun 30, 2026 | Filing ID: 000012
Read more